These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10808250)

  • 1. The use of GH as pharmacological agent (minireview).
    Wit JM
    Endocr Regul; 2000 Mar; 34(1):28-32. PubMed ID: 10808250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical strategy: growth hormone, indications, modalities and results].
    Weill J; Vanuxeem C
    Soins Pediatr Pueric; 2000; (193):26-8. PubMed ID: 11040796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth hormone therapy].
    Krysiak R; Okopień B; Gdula-Dymek A
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of research into growth hormone responsiveness.
    Rosenfeld RG
    Horm Res; 2009 Apr; 71 Suppl 2():71-4. PubMed ID: 19407500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of somatropin (recombinant growth hormone) in children of short stature.
    Mehta A; Hindmarsh PC
    Paediatr Drugs; 2002; 4(1):37-47. PubMed ID: 11817985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New conditions for the use of growth hormone and outcomes for different indications].
    Rochiccioli P; Tauber MT
    Ann Endocrinol (Paris); 1998 Nov; 59(4):296-9. PubMed ID: 9864549
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy in adults and children.
    Vance ML; Mauras N
    N Engl J Med; 1999 Oct; 341(16):1206-16. PubMed ID: 10519899
    [No Abstract]   [Full Text] [Related]  

  • 9. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
    Morin A; Guimarey L; Apezteguia M; Santucci Z
    Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and potential uses of growth hormone in therapeutics.
    Job JC; Chatelain P
    Nucl Med Biol; 1994 Apr; 21(3):401-6. PubMed ID: 9234304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four decades of growth hormone therapy for short children: what have we achieved?
    Guyda HJ
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4307-16. PubMed ID: 10599680
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
    Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
    Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental syndromes: growth hormone deficiency and treatment.
    Mazzanti L; Tamburrino F; Bergamaschi R; Scarano E; Montanari F; Torella M; Ballarini E; Cicognani A
    Endocr Dev; 2009; 14():114-34. PubMed ID: 19293579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
    Hampl R; Snajderova M; Lebl J; Lisa L; Dvorakova M; Hill M; Sulcova J; Starka L
    Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and congenital absence of the portal vein in a child receiving growth hormone therapy for turner syndrome.
    Morotti RA; Killackey M; Shneider BL; Repucci A; Emre S; Thung SN
    Semin Liver Dis; 2007 Nov; 27(4):427-31. PubMed ID: 17979078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A; Guimarey L; Santucci Z; Apezteguia M
    Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.